Intersint is a small R&D company working to gain more insight into cellular and molecular mechanisms involved in development of brain cancer glioblastoma and neurodegenerative diseases such as Alzheimer´s disease, Parkinson´s disease and multiple sclerosis. New insight is used in drug discovery and drug development.

Contact

Lillian Zernichow, MSc, PhD

Email: info@intersint.no

Phone: +47 45292660